BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-1440@pharmaconomics
DTSTAMP:20260707T034816Z
DTSTART;VALUE=DATE:20280101
DTEND;VALUE=DATE:20280102
SUMMARY:CLLS Approval — lasme-cel (estimated date)
DESCRIPTION:A final FDA approval decision on lasme-cel for relapsed or refractory B-cell acute lymphoblastic leukemia (r/r B-ALL) is expected ~ Jan 1\, 2028.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1627281/000117184326001805/exh_991.htm\n\nTrack it: https://www.pharmaconomics.com/e/1440
URL:https://www.pharmaconomics.com/e/1440
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:CLLS catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR